1,585
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Protection afforded by avian influenza vaccination programmes consisting of a novel RNA particle and an inactivated avian influenza vaccine against a highly pathogenic avian influenza virus challenge in layer chickens up to 18 weeks post-vaccination

, , , &
Pages 371-381 | Received 01 Feb 2019, Accepted 03 Apr 2019, Published online: 20 May 2019

References

  • Bertran, K., Balzli, C., Lee, D.H., Suarez, D.L., Kapczynski, D.R., & Swayne, D.E. (2017). Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus. Vaccine, 35, 6336–6344. doi: 10.1016/j.vaccine.2017.05.051
  • Capua, I. & Marangon, S. (2003). The use of vaccination as an option for the control of avian influenza. Avian Pathology, 32, 335–343. doi: 10.1080/0307945031000121077
  • Chen, H., & Bu, Z. (2009). Development and application of avian influenza vaccines in China. In R. Compans, & W. Orenstein (Eds.). Vaccines for Pandemic Influenza: Current Topics in Microbiology and Immunology (vol. 333, pp. 153–162). Berlin: Springer.
  • FASS. (2010). Guide for the Care and Use of Agricultural Animals in Research and Teaching. 3rd edn. Champaign, IL: Federation of Animal Science Societies.
  • Hartmann, S., Sid, H., & Rautenschlein, S. (2015). Avian metapneumovirus infection of chicken and turkey tracheal organ cultures: comparison of virus-host interactions. Avian Patholology, 44, 480–489. doi: 10.1080/03079457.2015.1086974
  • Hubby, B., Talarico, T., Maughan, M., Reap, E.A., Berglund, P., Kamrud, K. I., Copp, L., Lewis, W., Cecil, C., Norberg, P., Wagner, J., Watson, A., Negri, S., Burnett, B.K., Graham, A, Smith, J.F, Chulay, J.D. (2007). Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. Vaccine, 25, 8180–8189. doi: 10.1016/j.vaccine.2007.09.038
  • Kamrud, K.I., Alterson, K., Custer, M., Dudek, J., Goodman, C., Owens, G., & Smith, J.F. (2010). Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle. Journal of General Virology, 91, 1723–1727. doi: 10.1099/vir.0.020081-0
  • Kandeil, A., Mostafa, A., El-Shesheny, R., El-Taweel, A.N., Gomaa, M., Galal, H., Kayali, G., & Ali, M.A. (2017). Avian influenza H5N1 vaccination efficacy in Egyptian backyard poultry. Vaccine, 35, 6195–6201. doi: 10.1016/j.vaccine.2017.09.040
  • Kapczynski, D.R., Esaki, M., Dorsey, K.M., Jiang, H., Jackwood, M., Moraes, M., & Gardin, Y. (2015). Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus. Vaccine, 33, 1197–1205. doi: 10.1016/j.vaccine.2014.12.028
  • Kapczynski, D.R., Pantin-Jackwood, M.J., Spackman, E., Chrzastek, K., Suarez, D.L., & Swayne, D.E. (2017a). Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses. Vaccine, 35, 6345–6353. doi: 10.1016/j.vaccine.2017.04.042
  • Kapczynski, D.R., Sylte, M. J., Killian, M. L., Torchetti, M. K., Chrzastek, K., & Suarez, D. L. (2017b). Protection of commercial turkeys following inactivated or recombinant H5 vaccine application against the 2015 U.S. H5N2 clade 2.3.4.4 highly pathogenic avian influenza virus. Veterinary Immunology and Immunopathology, 191, 74–79. doi: 10.1016/j.vetimm.2017.08.001
  • Olsen, B., Munster, V.J., Wallensten, A., Waidenstrom, J., Osterhaus, A.D., & Fouchier, R.A. (2006). Global patterns of influenza A virus in wild birds. Science, 312, 384-388. doi: 10.1126/science.1122438
  • Pedersen, J.C. (2014). Hemagglutination-inhibition assay for influenza virus subtype identification and the detection and quantitation of serum antibodies to influenza virus. Methods in Molecular Biology, 1161, 11–25. doi: 10.1007/978-1-4939-0758-8_2
  • Perozo, F., Villegas, P., Dolz, R., Afonso, C.L., & Purvis, L.B. (2008). The VG/GA strain of Newcastle disease virus: mucosal immunity, protection against lethal challenge and molecular analysis. Avian Pathology, 37, 237–245. doi: 10.1080/03079450802043734
  • Preskenis, L.A., Ladman, B.S., & Gelb, J. (2017). Identification of Type A influenza viruses from wild birds on the Delmarva Peninsula, 2007-2010. Avian Diseases, 61, 83–89. doi: 10.1637/11461-062716-Reg
  • Rayner, J.O., Dryga, S.A., & Kamrud, K.I. (2002). Alphavirus vectors and vaccination. Reviews in Medical Virology, 12, 279-296. doi: 10.1002/rmv.360
  • Santos, J.J.S., Obadan, A.O., Garcia, S.C., Carnaccini, S., Kapczynski, D.R., Pantin-Jackwood, M., Suarez, D.L., & Perez, D.R. (2017). Short- and long-term protective efficacy against clade 2.3.4.4 H5N2 highly pathogenic avian influenza virus following prime-boost vaccination in turkeys. Vaccine, 35, 5637–5643. doi: 10.1016/j.vaccine.2017.08.059
  • Spackman, E., & Pantin-Jackwood, M.J. (2014). Practical aspects of vaccination of poultry against avian influenza virus. The Veterinary Journal, 202, 408-415. doi: 10.1016/j.tvjl.2014.09.017
  • Spackman, E., Senne, D.A., Myers, T.J., Bulaga, L.L., Garber, L.P., Perdue, M.L., Lohman, K., Daum, L.T., & Suarez, D.L. (2002). Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. Journal of Clinical Microbiology, 40, 3256–3260. doi: 10.1128/JCM.40.9.3256-3260.2002
  • Swayne, D.E. (2009). Avian influenza vaccines and therapies for poultry. Comparative Immunology Microbiology and Infectious Disease, 32, 351–363. doi: 10.1016/j.cimid.2008.01.006
  • Swayne, D.E., Pavade, G., Hamilton, K., Vallat, B., & Miyagishima, K. (2011). Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination. Reviews in Science and Technology, 30, 839–870. doi: 10.20506/rst.30.3.2081
  • Swayne, D.E., Suarez, D.L., Spackman, E., Jadhao, S., Dauphin, G., Kim-Torchetti, M., & Fouchier, R. (2015). Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia. Journal of Virology, 89, 3746–3762. doi: 10.1128/JVI.00025-15
  • Vander Veen, R.L., Loynachan, A.T., Mogler, M.A., Russell, B.J., Harris, D.L., & Kamrud, K.I. (2012). Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine. Vaccine, 30, 1944–1950. doi: 10.1016/j.vaccine.2012.01.030
  • Villegas, P. (2016). Titration of biological suspensions. In S.M. Williams, L. Dufour-Zavala, M. W. Jackwood, M.D. Lee, B. Lupiani, W.M. Reed, E. Spackman, and P.R. Woolcock (Eds.) A Laboratory Manual for the Isolation and Identification of Avian Pathogens 6th edn (pp. 355–360). Jacksonville, FL: American Association of Avian Pathologists.
  • World Organisation for Animal Health (OIE). (2018). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. http://www.oie.int/standard-setting/terrestrial-manual/access-online/

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.